A director at Nufarm Limited maiden bought 19,000 shares at 1.501USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Nufarm and ChrysaLabs partner to address barriers in carbon innovation measurement for sustainable aviation fuel production MELBOURNE, Australia, May 14, 2025 (GLOBE NEWSWIRE) -- MONTREAL, May 13, 2025 -- Nufarm is excited to announce its collaboration with ChrysaLabs, a leader in soil data, insights, and carbon measurement, to support the quantification of soil carbon sequestration benefits associated with Nufarm’s expansion of its Carinata production in South America. Carinata is a key crop in Nufarm’s bioenergy portfolio, delivering renewable biofuel feedstocks that enable the producti...
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement WEST SACRAMENTO, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Nutriterra® Total Omega-3 has received Health Canada approval as an ingredient in dietary supplements. Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) issued a product license, Natural Product Number (NPN) 80136254, which authorizes it to be marketed and sold as a novel, canola-based total omega-3 oil with the following health claims: Supports heart health and cardiovascular functionSupports normal brain fu...
Nufarm Partners with KD Nutra on Plant-Based Omega-3 Portfolio Expansion WEST SACRAMENTO, Calif., July 24, 2024 (GLOBE NEWSWIRE) -- Nuseed® Nutritional US Inc., the seed technologies platform of Nufarm Limited (ASX: NUF), is partnering with KD Nutra, a division of The KD Pharma Group, to expand offerings of plant-based long-chain omega-3 ingredients. This partnership allows both companies to leverage their expertise to offer the market new sources of omega-3 beyond marine sources and tap into the rapidly growing demand for alternatives. Nufarm is a global leader in developing agricul...
Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited (ASX:NUF)), granting Nufarm a commercial license to certain Omega-3 ...
Sumitomo Chemical is looking to sell its entire stake in Nufarm Ltd to raise A$338.3m (US$240.6m). Sumitomo Chemical had been a strategic investor, where it purchased 20% of the firm via a tender offer at A$14/share. The former had also acquired Nufarm’s South American businesses in mid-2020. While this would be a clean-up sale, the deal is a large one to process at 36 days ADV.
The general evaluation of NUFARM (AU), a company active in the Speciality Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date March 11, 2022, the closing price was AUD ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Summary Marketline's FMC Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by FMC Corporation since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and i...
Shares in Nufarm have continued to slide. Our recent notes have covered off on all pertinent drivers. It is more than well documented the company is working its way through drought in Australia and supply interruptions in its European business at a time when debt levels are elevated. The borrowings reflect acquisition of those same European businesses, and substantially increased working capital. The stress is heightened by Nufarm’s notoriously seasonal cash flows which leave less room for err...
Shares in Nufarm have continued to slide. Our recent notes have covered off on all pertinent drivers. It is more than well documented the company is working its way through drought in Australia and supply interruptions in its European business at a time when debt levels are elevated. The borrowings reflect acquisition of those same European businesses, and substantially increased working capital. The stress is heightened by Nufarm’s notoriously seasonal cash flows which leave less room for err...
No-moat Nufarm shares continue to struggle, down 14% to AUD 4.30 since April 12. We maintain our AUD 7.00 fair value estimate, holding to the view that the drivers of weakness are transitory. On the Best Ideas List, Nufarm’s price to fair value discount has now blown out to nearly 40%. The Australian drought and teething issues with recent European acquisitions hit near-term earnings and working capital, and U.S. lawsuits against glyphosate manufacturer Bayer further weigh on sentiment. Based ...
No-moat Nufarm shares continue to struggle, down 14% to AUD 4.30 since April 12. We maintain our AUD 7.00 fair value estimate, holding to the view that the drivers of weakness are transitory. On the Best Ideas List, Nufarm’s price to fair value discount has now blown out to nearly 40%. The Australian drought and teething issues with recent European acquisitions hit near-term earnings and working capital, and U.S. lawsuits against glyphosate manufacturer Bayer further weigh on sentiment. Based ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.